BMCTN 1101: A Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) vs HLA-Haploidentical Related Bone Marrow for Patients with Hematologic Malignancies (Spectrum Health Adult Bone Marrow Transplant Program)

Dana Farber 14-174: Study of Precursor Hematological Malignancies to Assess the Relationship Between Molecular Events of Progression and Clinical Outcome

Dana Farber 14-296: A Phase II Study of Ibrutinib in Combination with Fludarabine, Cyclophosphamide, and Rituximab (iFCR) in Previously Untreated, Younger Patients with Chronic Lymphocytic Leukemia

Dana Farber 14-396: A Multicenter Phase 1/1B Study of the Efficacy and Safety of the Novel P13K Delta Inhibitor TGR-1202 in Combination with Ibrutinib in Patients with Selected B Cell Malignancies

E1910: A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults

S1318: Ph II – Blinatumomab and POMP (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) for Pts >/= 65 Yrs w/ Newly Diagnosed Ph- ALL and of Dasatinib, Prednisone and Blinatumomab for Patients >/= 65 Yrs w/ Newly Diagnosed Ph+ ALL



By | 2017-09-08T14:04:17+00:00 September 8th, 2017|Categories: WMCC Clinical Trials|Tags: , |Comments Off on Leukemia

About the Author: